Advertisement
Screener

Insight Molecular Diagnostics Inc. (IMDX) Operating Lease, Liability, Noncurrent

2.8 / 5 stars · 68/120 Roast Me

Insight Molecular Diagnostics Inc. Operating Lease, Liability, Noncurrent

Insight Molecular Diagnostics Inc. (IMDX) had Operating Lease, Liability, Noncurrent of $3.66 million as of 2021-03-31, per its 10-Q filed 2021-05-17.

Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2021-05-17

  • 2021-03-31: Operating Lease, Liability, Noncurrent $3.66M.
  • 2020-09-30: Operating Lease, Liability, Noncurrent $3.65M.
  • 2020-06-30: Operating Lease, Liability, Noncurrent $3.09M.
  • 2020-03-31: Operating Lease, Liability, Noncurrent $3.06M.
Period endOperating Lease, Liability, Noncurrent
2021-03-31$3.66M
10-Q · filed 2021-05-17
2020-09-30$3.65M
10-Q · filed 2020-11-12
2020-06-30$3.09M
10-Q · filed 2020-07-29
2020-03-31$3.06M
10-Q · filed 2020-05-12
2019-09-30$316.00K
10-Q · filed 2019-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92